Trials / Conditions / Metastatic Non-Small Cell Lung Carcinoma
Metastatic Non-Small Cell Lung Carcinoma
5 registered clinical trials studyying Metastatic Non-Small Cell Lung Carcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic NCT03892096 | Cadex Genomics | — |
| Recruiting | Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treat NCT03808337 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Pembrolizumab for Metastatic NSCLC Patients Expressing PD-L1 Who Have Their Own PDX NCT03134456 | Samsung Medical Center | Phase 4 |
| Completed | Perfusion-Induced Hyperthermia for Metastatic Carcinoma NCT02409108 | Jonathan Kiev | N/A |
| Completed | The Jules Bordet Institute Molecular Profiling Program Feasibility Trial NCT01932489 | Jules Bordet Institute | N/A |